Quick Answer
AVAI BIO, INC. reported Gross Profit of -$40.5 thousand for fiscal year 2023.
AVAI BIO, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2023 | -$40.5K | -119.2% |
| 2022 | $210.8K | +1374.8% |
| 2021 | -$16.5K | +93.5% |
| 2020 | -$256.3K | — |
| 2019 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| December 31, 2022 | -$71.5K | -124.5% | -1185.2% |
| September 30, 2022 | $6.6K | +107.1% | -73.1% |
| June 30, 2022 | $24.5K | -95.5% | -91.6% |
| December 31, 2021 | $292.0K | -15.7% | +412.5% |
| September 30, 2021 | -$93.4K | -206.9% | -117.2% |
| June 30, 2021 | $542.9K | +541.5% | +56.8% |
| December 31, 2020 | $346.2K | — | +296.1% |
| September 30, 2020 | $87.4K | — | +3.3% |
- AVAI BIO, INC. showed a decrease of -119.2% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from AVAI BIO, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on July 3, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: